Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Metadata
Title
Falls in nonagenarians living in their own homes: The NonaSantfeliu study
Authors
F. Formiga
A. Ferrer
E. Duaso
C. Olmedo
R. Pujol
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
The journal of nutrition, health & aging / Issue 4/2008
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/BF02982633

Other articles of this Issue 4/2008

The journal of nutrition, health & aging 4/2008 Go to the issue

OriginalPaper

Dietary and genetic compromise in folate availability reduces acetylcholine, cognitive performance and increases aggression: Critical role of S-adenosyl methionine

OriginalPaper

A randomized trial of the impact of a specific care plan in 1120 Alzheimer’s patients (PLASA study) over a two-year period: Design and baseline data

OriginalPaper

Why don’t elderly hospital inpatients eat adequately?

ReviewPaper

Delirium in hospitalised older persons: Review

OriginalPaper

A practical approach to estimate resting energy expenditure in frail elderly people

OriginalPaper

International publications from the French geriatric teams: Evolution in the course of last 22 years

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits